{"organizations": [], "uuid": "64db74ea91ef75852dd45557644079bcc0e00a8d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/05/11/business-wire-taro-to-announce-full-year-results-on-may-17-2018.html", "country": "US", "domain_rank": 767, "title": "Taro to Announce Full Year Results on May 17, 2018", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.543, "site_type": "news", "published": "2018-05-11T23:00:00.000+03:00", "replies_count": 0, "uuid": "64db74ea91ef75852dd45557644079bcc0e00a8d"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/05/11/business-wire-taro-to-announce-full-year-results-on-may-17-2018.html", "ord_in_thread": 0, "title": "Taro to Announce Full Year Results on May 17, 2018", "locations": [], "entities": {"persons": [{"name": "taro", "sentiment": "negative"}], "locations": [{"name": "hawthorne", "sentiment": "none"}, {"name": "n.y.", "sentiment": "none"}], "organizations": [{"name": "company", "sentiment": "none"}, {"name": "nyse", "sentiment": "none"}, {"name": "taro pharmaceutical industries ltd.", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Earnings Call to Discuss Results to be Conducted Friday, May 18 at 8:00 am EDT\nHAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for year ended March 31, 2018, on Thursday, May 17, 2018.\nThe Company will conduct an earnings call at 8:00 am EDT on Friday, May 18, 2018, where senior management will discuss the Company’s performance and answer questions from participants.\nThe release will be accessible on Taro’s website at www.taro.com .\nEarnings Call (8:00 am EDT on Friday, May 18, 2018)\nTo participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com . A transcript of this earnings call will also be available on the website.\nSummary of events\nEvent Date and time Telephone number / website\nEarnings release May 17, 2018 (AMC) www.taro.com\nEarnings conference call\nMay 18, 2018\nParticipant Toll-Free Dial-In Number: +1 (844) 421-0601\n8:00 am EDT\nParticipant International Dial-In Number: +1 (716) 247-5800\nID: 3249428\nVia audio webcast, details of which will be made available on www.taro.com\nReplay of conference call\nMay 18, 2018 to\n+ 1 (855) 859-2056 or +1 (404) 537-3406\nMay 31, 2018\nID: 3249428\nVia audio webcast playback, details of which will be made available on www.taro.com\nAbout Taro\nTaro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com .\nView source version on businesswire.com : https://www.businesswire.com/news/home/20180511005525/en/\nTaro Pharmaceutical Industries Ltd.\nMariano A. Balaguer, 914-345-9001\nVP, CFO\nMariano.Balaguer@taro.com\nor\nWilliam J. Coote, 914-345-9001\nAVP, Business Finance, Treasurer and Investor Relations\nWilliam.Coote@taro.com\nSource: Taro Pharmaceutical Industries Ltd.", "external_links": ["http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.taro.com&esheet=51805066&newsitemid=20180511005525&lan=en-US&anchor=www.taro.com&index=3&md5=eec66398853ca4256f908ed1ecde85d9", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.taro.com&esheet=51805066&newsitemid=20180511005525&lan=en-US&anchor=www.taro.com&index=6&md5=bdf3f71de56b969307c62fd8bbdbf749", "https://www.businesswire.com/news/home/20180511005525/en/", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.taro.com&esheet=51805066&newsitemid=20180511005525&lan=en-US&anchor=www.taro.com&index=2&md5=ff8aa54dd34c0451d10ab0643dbc55e7", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.taro.com&esheet=51805066&newsitemid=20180511005525&lan=en-US&anchor=www.taro.com&index=1&md5=341013b23f5b4de636251ad4db945c32", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.taro.com&esheet=51805066&newsitemid=20180511005525&lan=en-US&anchor=www.taro.com&index=5&md5=de183ecd8d72ee8047a4a7fdead17983", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.taro.com&esheet=51805066&newsitemid=20180511005525&lan=en-US&anchor=www.taro.com&index=4&md5=159e0c47b302593571cd9c3a22b18e5a"], "published": "2018-05-11T23:00:00.000+03:00", "crawled": "2018-05-12T01:26:14.008+03:00", "highlightTitle": ""}